129 related articles for article (PubMed ID: 2778187)
1. Decreased leukocyte ferrochelatase activity in erythropoietic protoporphyria.
Kondo M; Ohe M; Mizuguchi M
J Dermatol; 1989 Apr; 16(2):116-21. PubMed ID: 2778187
[TBL] [Abstract][Full Text] [Related]
2. Diminished erythroid ferrochelatase activity in protoporphyria.
Bottomley SS; Tanaka M; Everett MA
J Lab Clin Med; 1975 Jul; 86(1):126-31. PubMed ID: 1151134
[TBL] [Abstract][Full Text] [Related]
3. Zinc chelatase in human lymphocytes: detection of the enzymatic defect in erythropoietic protoporphyria.
Nunn AV; Norris P; Hawk JL; Cox TM
Anal Biochem; 1988 Oct; 174(1):146-50. PubMed ID: 3218729
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of protoporphyrin IX from delta-aminolevulinic acid in bovine skin fibroblasts with hereditary erythropoietic protoporphyria. A gene-dosage effect.
Sassa S; Schwartz S; Ruth G
J Exp Med; 1981 May; 153(5):1094-101. PubMed ID: 6788885
[TBL] [Abstract][Full Text] [Related]
5. Studies in porphyria: functional evidence for a partial deficiency of ferrochelatase activity in mitogen-stimulated lymphocytes from patients with erythropoietic protoporphyria.
Sassa S; Zalar GL; Poh-Fitzpatrick MB; Anderson KE; Kappas A
J Clin Invest; 1982 Apr; 69(4):809-15. PubMed ID: 6804493
[TBL] [Abstract][Full Text] [Related]
6. Induction of hepatic aminolevulinate acid synthetase activity by isoflurane in a genetic model for erythropoietic protoporphyria.
Buzaleh AM; Morán-Jiménez MJ; Garcia-Bravo M; Sampedro A; Batlle AM; Enriquez de Salamanca R; Fontanellas A
Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):38-44. PubMed ID: 19268000
[TBL] [Abstract][Full Text] [Related]
7. Protoporphyrin accumulation by mitogen stimulated lymphocytes and protoporphyrinogen oxidase activity in patients with porphyria variegata and erythropoietic protoporphyria: evidence for deficiency of protoporphyrinogen oxidase and ferrochelatase in both diseases.
Siepker LJ; Kramer S
Br J Haematol; 1985 May; 60(1):65-74. PubMed ID: 3924091
[TBL] [Abstract][Full Text] [Related]
8. X-linked dominant protoporphyria: The first reported Japanese case.
Ninomiya Y; Kokunai Y; Tanizaki H; Akasaka E; Nakano H; Moriwaki S
J Dermatol; 2016 Apr; 43(4):414-8. PubMed ID: 26387792
[TBL] [Abstract][Full Text] [Related]
9. Acute ethanol ingestion and haem biosynthesis in healthy subjects.
McColl KE; Thompson GG; Moore MR; Goldberg A
Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):107-12. PubMed ID: 6780356
[TBL] [Abstract][Full Text] [Related]
10. Different characteristics of ferrochelatase in cultured fibroblasts of erythropoietic protoporphyria patients and normal controls.
Blom C; Klasen EC; Van Steveninck J
Biochim Biophys Acta; 1990 Jul; 1039(3):339-42. PubMed ID: 2378891
[TBL] [Abstract][Full Text] [Related]
11. The biosynthesis of haem in congenital (erythropoietic) porphyria.
Moore MR; Thompson GG; Goldberg A; Ippen H; Seubert A; Seubert S
Int J Biochem; 1978; 9(12):933-8. PubMed ID: 744299
[No Abstract] [Full Text] [Related]
12. Protoporphyrinogen oxidase and ferrochelatase in porphyria variegata.
Viljoen DJ; Cummins R; Alexopoulos J; Kramer S
Eur J Clin Invest; 1983 Aug; 13(4):283-7. PubMed ID: 6413214
[TBL] [Abstract][Full Text] [Related]
13. Heme biosynthesis in sideroblastic anemia.
Pasanen AV; Salmi M; Vuopio P; Tenhunen R
Int J Biochem; 1980; 12(5-6):969-74. PubMed ID: 7450158
[No Abstract] [Full Text] [Related]
14. Enzyme abnormalities in the porphyrias.
Brodie MJ; Moore MR; Goldberg A
Lancet; 1977 Oct; 2(8040):699-701. PubMed ID: 71507
[TBL] [Abstract][Full Text] [Related]
15. Loss-of-function ferrochelatase and gain-of-function erythroid-specific 5-aminolevulinate synthase mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of X-linked protoporphyria.
Balwani M; Doheny D; Bishop DF; Nazarenko I; Yasuda M; Dailey HA; Anderson KE; Bissell DM; Bloomer J; Bonkovsky HL; Phillips JD; Liu L; Desnick RJ;
Mol Med; 2013 Apr; 19(1):26-35. PubMed ID: 23364466
[TBL] [Abstract][Full Text] [Related]
16. Ferrochelatase activities in patients with erythropoietic protoporphyria and their families.
Goerz G; Bunselmeyer S; Bolsen K; Schürer NY
Br J Dermatol; 1996 May; 134(5):880-5. PubMed ID: 8736329
[TBL] [Abstract][Full Text] [Related]
17. The treatment of acute intermittent porphyria with laevulose.
Brodie MJ; Moore MR; Thompson GG; Goldberg A
Clin Sci Mol Med; 1977 Oct; 53(4):365-71. PubMed ID: 913061
[TBL] [Abstract][Full Text] [Related]
18. Genetic heterogeneity in erythropoietic protoporphyria: a study of the enzymatic defect in nine affected families.
Norris PG; Nunn AV; Hawk JL; Cox TM
J Invest Dermatol; 1990 Sep; 95(3):260-3. PubMed ID: 2384686
[TBL] [Abstract][Full Text] [Related]
19. Haem biosynthesis in cutaneous hepatic porphyria: comparison with alcoholism and liver disease.
Brodie MJ; Thompson GG; Moore MR; McColl KE; Goldberg A; Hardie RA; Hunter JA
Acta Hepatogastroenterol (Stuttg); 1979 Apr; 26(2):122-8. PubMed ID: 463487
[TBL] [Abstract][Full Text] [Related]
20. [Decreased heme synthetase activity in erythroblasts in two patients with erythropoietic protoporphyria (author's transl)].
Kaneko K; Sanada M; Imaizumi S; Koike T; Miyashita M; Shibata A
Rinsho Ketsueki; 1981 Dec; 22(12):2023-33. PubMed ID: 7345186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
